BioTech Medics (BioTech Medics) Debt-to-Revenue : 0.00 (As of . 20)

View and export this data going back to . Start your Free Trial

What is BioTech Medics Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

BioTech Medics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. BioTech Medics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. BioTech Medics's annualized Revenue for the quarter that ended in . 20 was $0.00 Mil.

BioTech Medics Debt-to-Revenue Historical Data

The historical data trend for BioTech Medics's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioTech Medics Debt-to-Revenue Chart

BioTech Medics Annual Data

Trend

Debt-to-Revenue

BioTech Medics Quarterly Data

Debt-to-Revenue

Competitive Comparison of BioTech Medics's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, BioTech Medics's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioTech Medics's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioTech Medics's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where BioTech Medics's Debt-to-Revenue falls into.

BioTech Medics Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

BioTech Medics's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(	+	)	/	N/A
	=	N/A

BioTech Medics's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(	+	)	/	0
	=	N/A

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (. 20) Revenue data.

BioTech Medics Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioTech Medics's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BioTech Medics (BioTech Medics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioTech Medics Inc (OTCPK:BMCS) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

5850 Canoga Avenue, Suite 400, Woodland Hills, Los Angeles, CA, USA, 91367

Website

http://www.biotecmedics.com

BioTech Medics Inc is a medical-based holding company. The company operates through four divisions namely Medical, Nutraceutical Products, Sports Medicine, and Research and Development.